Login / Signup

Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis.

Emily RickardEmma CarmelPiotr Ozieranski
Published in: BMJ open (2023)
Our findings suggest a strategic approach to payments tailored to countries' policy and decision-making context, indicating there may be specific vulnerabilities to financial conflicts of interest at subnational level. Payment differences between countries may be occurring in other countries, particularly those with decentralised health systems and/or high levels of independence across its decision-making authorities. We call for a single database containing all recipient types, full location details and published with associated descriptive and network statistics.
Keyphrases
  • decision making
  • network analysis
  • healthcare
  • cross sectional
  • mental health
  • randomized controlled trial
  • public health
  • emergency department
  • health insurance
  • smoking cessation
  • affordable care act
  • adverse drug